Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Sell

Wall Street Data Solutions Rating

Neutral

B

Finch Therapeutics Group, Inc. Common Stock (FNCH)

Biological Products, (no Disgnostic Substances)

https://www.finchtherapeutics.com

Finch Therapeutics Group Inc is a clinical-stage microbiome therapeutics company. It is leveraging Human-First Discovery platform to develop a novel class of orally administered biological drugs. It is developing novel therapeutics to deliver missing microbes and their clinically relevant biochemical functions to correct dysbiosis and the diseases that emerge from it. The lead product candidate is CP101 which delivers a complete microbiome and is being developed initially for the treatment of patients with recurrent Clostridioides difficile infection.

75 STATE STREET, SUITE 100
BOSTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/19/2021

Market Cap

20,634,016

Shares Outstanding

1,610,000

Weighted SO

1,605,763

Total Employees

N/A

Upcoming Earnings

N/A

Beta

0.4140

Last Div

0.0000

Range

0.8-13.41

Chg

0.8300

Avg Vol

32112

Mkt Cap

20634016

Exch

NASDAQ

Country

US

Phone

617 229 6499

DCF Diff

16.8205

DCF

-3.9704

Div Yield

0.0000

P/S

7.2527

EV Multiple

-1.7095

P/FV

1.4512

Div Yield %

0.0000

P/E

-1.4565

PEG

-0.0418

Payout

0.0000

Current Ratio

3.8725

Quick Ratio

3.8725

Cash Ratio

3.5937

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

76.1511

CCC

-76.1511

Gross Margin

0.9511

Op Margin

-6.9367

Pretax Margin

-4.9796

Net Margin

-4.9796

Eff Tax Rate

-0.0794

ROA

-0.3108

ROE

-0.6914

ROCE

-0.4800

NI/EBT

1.0000

EBT/EBIT

0.7179

EBIT/Rev

-6.9367

Debt Ratio

0.6361

D/E

2.0388

LT Debt/Cap

0.6542

Total Debt/Cap

0.6709

Int Coverage

0.2027

CF/Debt

-0.4598

Equity Multi

3.2053

Rec Turnover

0.0000

Pay Turnover

4.7931

Inv Turnover

0.0000

FA Turnover

0.1096

Asset Turnover

0.0624

OCF/Share

-8.3007

FCF/Share

-8.2920

Cash/Share

9.9859

OCF/Sales

-4.6851

FCF/OCF

0.9989

CF Coverage

-0.4598

ST Coverage

-6.3653

CapEx Coverage

-952.0714

Div&CapEx Cov

-952.0714

P/BV

1.4512

P/B

1.4512

P/S

7.2527

P/E

-1.4565

P/FCF

-1.5497

P/OCF

-1.5481

P/CF

-1.5481

PEG

-0.0418

P/S

7.2527

EV Multiple

-1.7095

P/FV

1.4512

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation